Latest results in Health Research

NHS whole working life, cardiology day job, R&D director local and national UKRD group, first CRIO at Royal Free passionate about research and all therapeutic innovations – drugs, devices (pacing and stents), diagnostics (biomarkers and wearables) and digital (AI predictive algorithms and data insights and clinical pathways).

Have 1st ever Cerner heart failure pathway to nudge diagnoses (3-8x increased) and guidance prescribing (now top 10% adherence) and reduced mortality in hospital with 41,000 patient journeys data. Published >120 papers and used to observation to interventional research studies. recently on predicting arrhythmias and heart failure and now CVD from retinal imaging.

Graeme is Professor of Genomics and Ophthalmology at The University of Manchester and Consultant Geneticist at Manchester University Hospitals NHS Foundation Trust. His major research interest is the investigation of genetic disorders associated with visual disability.

He runs a busy clinical service, as well as overseeing scientific teams providing accredited genomic testing for inherited eye disorder patients. His overarching aims are to improve the diagnosis, management and treatment of such conditions, and the Gen-o project is a core proponent of this work.

Marko is the Chief Technology Officer for Our Future Health, joining late 2020 as the first technologist. He has recruited a team who have created and scaled a complex and reliable set of platforms to recruit volunteers, manage appointments for blood, produce quarterly data releases enabling scientific research in a trusted research environment and gain multiple security certifications. Our Future Health is the UK’s largest health research programme and still growing.

Previously, as Head of Innovation and AI at Huma, he was creating market-leading digital health technologies. He served 5 years on the board of NHS Digital, leading on technology and innovation. As Chief Technology Officer at Digital Catapult, he worked across technologies including machine learning, 5G, the internet of things, virtual and augmented reality and blockchain. Marko has been instrumental in bringing several new technologies to market. At a start-up called State he helped to launch a digital global opinion network. Formerly, Marko was Head of Innovation at lastminute.com, where his team launched an array of award-winning mobile apps. Marko studied Computer Science at Cambridge University and has a PhD in Computer Science (AI) from Stanford, where he led foundational work on recommender systems.

Dr Pahini Pandya is the CEO and Founder of Panakeia Technologies, which enables rapid multi-omics profiling in minutes directly from routinely used tissue images, using AI and without the need for wet-lab assays. Trained as a cancer researcher Dr. Pahini Pandya spent the last decade furthering translational research in the field.

She pursued a PhD in cancer biophysics at King’s College London, a postdoc at the University of Cambridge and has several publications in top journals. Educated at the Stanford and Cambridge business schools, Pahini has also held several leadership positions across entrepreneurial organisations and helped numerous start-ups commercialise research. She has been recognised as Global Shaper by the World Economic Forum, and received multiple awards for entrepreneurship.